The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by patients worldwide to treat a variety of diseases and serious medical conditions. PPTA member companies produce approximately 80% of the plasma protein therapies in the U.S. and 60% of those manufactured in Europe.
PPTA works globally to:
Alabama Lowers Minimum Donation Age to 18 +
PPTA would like to recognize Alabama for demonstrating the important role source plasma plays in saving and improving patients’ lives.Read More
PPTA Recognizes World PI Week: April 22-29, 2015 +
April 20, 2015—The Plasma Protein Therapeutics Association stands together with the global primary immunodeficiency community to promote World PI Week, a global campaign aimed to raise awareness and improve diagnosis and treatment of PID.Read More
PPTA Recognizes World Hemophilia Day–April 17, 2015 +
The Source, the international magazine of the plasma protein therapeutics industry is published quarterly. Read the current issue.